• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压患者不同年龄全因死亡率和死因特异性死亡率与危险因素之间的关联及其归因负担。

Associations and attributable burden between risk factors and all-cause and cause-specific mortality at different ages in patients with hypertension.

机构信息

Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Department of Family Medicine, The University of Hong Kong - Shenzhen Hospital, Shenzhen, China.

出版信息

Hypertens Res. 2024 Aug;47(8):2053-2063. doi: 10.1038/s41440-024-01717-4. Epub 2024 May 23.

DOI:10.1038/s41440-024-01717-4
PMID:38783145
Abstract

It remains unclear the age-specific associations of risk factors with deaths and mortality burden attributable across age. In a territory-wide retrospective cohort, 1,012,228 adults with hypertension were identified. Comorbidities including diabetes, chronic kidney disease (CKD), cardiovascular disease (CVD), heart failure, and cancer, and risk factors including current smoking and suboptimal control of blood pressure (BP), glucose and low-density lipoprotein cholesterol were defined. Associations of comorbidities/risk factors with all-cause and cause-specific mortality across age groups (18-54, 55-64, 65-74, and ≥75 years) were assessed. Population attributable fractions were also quantified. During a median follow-up of 10.7 years, 244,268 (24.1%) patients died, with pneumonia (7.2%), cancer (5.1%), and CVD (4.2%) being the leading causes. Despite increasing deaths with age, relative risk of mortality related to comorbidities/risk factors decreased with age; similar patterns were found for cause-specific mortality. The assessed risk factors accounted for 24.0% (95% CI 22.5%, 25.4%) deaths, with highest proportion in the youngest group (33.5% [28.1%, 38.5%] in 18-54 years vs 19.4% [17.0%, 21.6%] in ≥75 years). For mortality burden, CKD was the overall leading risk factor (12.7% [12.4%, 12.9%]) with higher proportions in older patients (11.1-13.1% in ≥65 years), while diabetes was the leading risk factor in younger patients (15.9-13.5% in 18-54 years). The association of comorbidities or risk factors with mortality is stronger in younger patients with hypertension, despite lower absolute mortality in young patients than in the elderly. Leading risk factors differed across age, highlighting the importance of targeted and precise risk management.

摘要

目前尚不清楚特定年龄的风险因素与全因死亡和各年龄段归因死亡负担之间的关系。在一项全港范围的回顾性队列研究中,共确定了 1012228 名高血压成年人。共病包括糖尿病、慢性肾脏病(CKD)、心血管疾病(CVD)、心力衰竭和癌症,以及风险因素包括当前吸烟和血压(BP)、血糖和低密度脂蛋白胆固醇控制不理想。评估了共病/风险因素与各年龄段(18-54 岁、55-64 岁、65-74 岁和≥75 岁)全因和死因特异性死亡率之间的关系。还量化了人群归因分数。在中位随访 10.7 年后,244268 名(24.1%)患者死亡,主要死因是肺炎(7.2%)、癌症(5.1%)和 CVD(4.2%)。尽管随着年龄的增长,死亡人数不断增加,但与共病/风险因素相关的死亡率的相对风险随着年龄的增长而降低;死因特异性死亡率也存在类似的模式。评估的风险因素占死亡人数的 24.0%(95%CI 22.5%,25.4%),在最年轻的组中占比最高(18-54 岁组为 33.5%[28.1%,38.5%],≥75 岁组为 19.4%[17.0%,21.6%])。在死亡负担方面,CKD 是总体上的主要风险因素(12.7%[12.4%,12.9%]),在年龄较大的患者中占比更高(≥65 岁患者中为 11.1-13.1%),而在年轻患者中糖尿病是主要风险因素(18-54 岁患者中为 15.9-13.5%)。尽管年轻患者的绝对死亡率低于老年患者,但高血压合并共病或风险因素的患者与死亡率的关联更强。不同年龄的主要风险因素不同,突出了有针对性和精确的风险管理的重要性。

相似文献

1
Associations and attributable burden between risk factors and all-cause and cause-specific mortality at different ages in patients with hypertension.高血压患者不同年龄全因死亡率和死因特异性死亡率与危险因素之间的关联及其归因负担。
Hypertens Res. 2024 Aug;47(8):2053-2063. doi: 10.1038/s41440-024-01717-4. Epub 2024 May 23.
2
Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong.年龄特异性人口归因风险因素与 2 型糖尿病全因和死因死亡率:对香港超过 36 万人 6 年前瞻性队列研究的分析。
PLoS Med. 2023 Jan 30;20(1):e1004173. doi: 10.1371/journal.pmed.1004173. eCollection 2023 Jan.
3
Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.在加拿大,167500 例 COVID-19 患者中,先前存在的合并症与死亡率和疾病严重程度的关系:一项基于人群的队列研究。
PLoS One. 2021 Oct 5;16(10):e0258154. doi: 10.1371/journal.pone.0258154. eCollection 2021.
4
Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.2016 年全球疾病负担研究:1990 年至 2016 年 195 个国家和地区的酒精使用和负担:系统分析。
Lancet. 2018 Sep 22;392(10152):1015-1035. doi: 10.1016/S0140-6736(18)31310-2. Epub 2018 Aug 23.
5
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
6
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
7
The frailty index is a predictor of cause-specific mortality independent of familial effects from midlife onwards: a large cohort study.衰弱指数是从中年开始独立于家族影响预测特定原因死亡率的指标:一项大型队列研究。
BMC Med. 2019 May 15;17(1):94. doi: 10.1186/s12916-019-1331-8.
8
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019.年龄性别差异与下呼吸道感染全球负担及相关风险因素,1990-2019 年:基于 2019 年全球疾病负担研究结果
Lancet Infect Dis. 2022 Nov;22(11):1626-1647. doi: 10.1016/S1473-3099(22)00510-2. Epub 2022 Aug 11.
9
The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China.中国高血压的负担及与心血管死亡率相关的风险。
JAMA Intern Med. 2016 Apr;176(4):524-32. doi: 10.1001/jamainternmed.2016.0190.
10
Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease.年龄相关的多种合并症与美国慢性肾脏病患者死亡率的相关性。
Am J Nephrol. 2022;53(8-9):652-662. doi: 10.1159/000526254. Epub 2022 Oct 7.

引用本文的文献

1
Review of Blood Pressure Control in Vulnerable Older Adults: The Role of Frailty and Sarcopenia.脆弱老年人群血压控制的综述:衰弱和肌肉减少症的作用
J Vasc Dis. 2025 Jun;4(2). doi: 10.3390/jvd4020018. Epub 2025 May 14.
2
Efficacy and safety of esaxerenone in hypertensive patients with chronic kidney disease, with or without type 2 diabetes mellitus: a pooled analysis of five clinical studies.依折麦布在伴或不伴2型糖尿病的慢性肾脏病高血压患者中的疗效与安全性:五项临床研究的汇总分析
Hypertens Res. 2025 Jun 30. doi: 10.1038/s41440-025-02259-z.
3
Early onset of hypertension and increased relative risks of chronic kidney disease and mortality: two population-based cohort studies in United Kingdom and Hong Kong.

本文引用的文献

1
Association of eGFR slope with all-cause mortality, macrovascular and microvascular outcomes in people with type 2 diabetes and early-stage chronic kidney disease.估算肾小球滤过率(eGFR)斜率与2型糖尿病合并早期慢性肾脏病患者全因死亡率、大血管和微血管结局的关联
Diabetes Res Clin Pract. 2023 Nov;205:110924. doi: 10.1016/j.diabres.2023.110924. Epub 2023 Sep 30.
2
Assessment of Hypertension Complications and Health Service Use 5 Years After Implementation of a Multicomponent Intervention.评估综合干预实施 5 年后高血压并发症和卫生服务利用情况。
JAMA Netw Open. 2023 May 1;6(5):e2315064. doi: 10.1001/jamanetworkopen.2023.15064.
3
高血压的早发以及慢性肾病和死亡相对风险的增加:英国和香港的两项基于人群的队列研究
Hypertens Res. 2025 Mar 26. doi: 10.1038/s41440-025-02188-x.
Dementia occurring over a 32-year follow-up attributable to hypertension observed at different ages: Implications for dementia prevention.
在不同年龄段观察到的高血压导致的痴呆症在 32 年随访中发生:对痴呆症预防的启示。
Alzheimers Dement. 2023 Aug;19(8):3435-3447. doi: 10.1002/alz.12984. Epub 2023 Feb 18.
4
What did we learn from the International Databases on Ambulatory and Home Blood Pressure in Relation to Cardiovascular Outcome?我们从国际动态血压和家庭血压数据库与心血管结局研究中学到了什么?
Hypertens Res. 2023 Apr;46(4):934-949. doi: 10.1038/s41440-023-01191-4. Epub 2023 Feb 3.
5
Hypertension in China: epidemiology and treatment initiatives.中国高血压:流行病学和治疗措施。
Nat Rev Cardiol. 2023 Aug;20(8):531-545. doi: 10.1038/s41569-022-00829-z. Epub 2023 Jan 11.
6
Blood pressure in heart failure management and prevention.心力衰竭管理与预防中的血压
Hypertens Res. 2023 Apr;46(4):817-833. doi: 10.1038/s41440-022-01158-x. Epub 2023 Jan 5.
7
Hypertension management in patients with cardiovascular comorbidities.心血管合并症患者的高血压管理。
Eur Heart J. 2023 Jun 20;44(23):2066-2077. doi: 10.1093/eurheartj/ehac395.
8
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.非白蛋白尿性糖尿病肾病与 2 型糖尿病全因死亡率及心血管和肾脏结局的关系:来自香港糖尿病生物库的研究结果。
Am J Kidney Dis. 2022 Aug;80(2):196-206.e1. doi: 10.1053/j.ajkd.2021.11.011. Epub 2022 Jan 6.
9
Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality.高血压发病年龄与心血管疾病及死亡率的关系。
J Am Coll Cardiol. 2020 Jun 16;75(23):2921-2930. doi: 10.1016/j.jacc.2020.04.038.
10
2020 International Society of Hypertension Global Hypertension Practice Guidelines.2020年国际高血压学会全球高血压实践指南
Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6.